Summary. Doripenem, a member of the β-lactam class of antibiotics, is the newest addition to the carbapenems. It exhibits concentration-independent bactericidal activity against gram-positive ...

The carbapenem antibiotics (imipenem, meropenem and doripenem) are considered the agents of choice for A. baumannii infections. The presence of resistance to these agents constrains therapeutic ...

Increasing incidence of bloodstream infections with Enterobacterales resistant to carbapenem antibiotics poses a significant threat to patients and healthcare systems in the EU/EEA Furthermore ...

We reviewed series and case reports of carbapenem-resistant (CR) GN-bacteria in this targeted population to describe the epidemiologic and clinical factors associated with the occurrence of CR ...

Carbapenem-resistant Enterobacterales (CRE ... Even though several new antibiotics are available, treatment options remain limited overall. Immediate action is essential to control this problem ...

Wockhardt Limited announced that its innovative antibiotic, Zaynich (Zidebactam/Cefepime), demonstrated over 97% clinical efficacy in treating serious infections ...

Carbapenem-resistant Enterobacteriaceae (CRE ... Disruption of the microbiome, caused by factors such as antibiotic use, diet, and disease, can create ecological niches that favor the colonization of ...

That includes improving local data about co-morbidities that can affect the ability of antibiotics to work. Among the most important AMR targets are carbapenem-resistant bacteria. In Latin America ...